Zibotentan
Showing 1 - 25 of 28
Liver Cirrhosis Trial in Worldwide (Part A: Placebo (matching zibotentan capsule & matching dapagliflozin tablet), Part A:
Not yet recruiting
- Liver Cirrhosis
- Part A: Placebo (matching zibotentan capsule & matching dapagliflozin tablet)
- +6 more
-
Wien, Austria
- +7 more
Aug 24, 2022
Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)
Enrolling by invitation
- Chronic Kidney Diseases
- Zibotentan
- +3 more
-
Aurora, Colorado
- +5 more
Oct 18, 2022
Healthy Female Participants Trial in Brooklyn (Zibotentan, EE/LNG)
Not yet recruiting
- Healthy Female Participants
- Zibotentan
- EE/LNG
-
Brooklyn, MarylandResearch Site
Aug 16, 2022
Chronic Kidney Disease Trial in Brooklyn (Zibotentan (Treatment A), Dapagliflozin (Treatment A), Zibotentan/Dapagliflozin -
Completed
- Chronic Kidney Disease
- Zibotentan (Treatment A)
- +3 more
-
Brooklyn, MarylandResearch Site
Nov 22, 2021
Hepatic Impairment, Renal Impairment Trial in Sofia (Zibotentan)
Completed
- Hepatic Impairment
- Renal Impairment
- Zibotentan
-
Sofia, BulgariaResearch Site
Jan 26, 2022
Chronic Kidney Disease With High Proteinuria Trial in Worldwide (Zibotentan/Dapagliflozin, Dapagliflozin)
Not yet recruiting
- Chronic Kidney Disease With High Proteinuria
-
Bakersfield, California
- +99 more
Oct 17, 2023
Microvascular Angina Trial in Glasgow (Zibotentan, Placebo oral tablet)
Recruiting
- Microvascular Angina
- Zibotentan
- Placebo oral tablet
-
Glasgow, United KingdomNHS Greater Glasgow and Clyde
Dec 1, 2020
Chronic Kidney Disease Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)
Recruiting
- Chronic Kidney Disease
- Zibotentan
- +2 more
-
Huntsville, Alabama
- +251 more
Dec 22, 2022
Microvascular Angina Trial in Cambridge (Blood tests including genotyping, Exercise Tolerance Test)
Recruiting
- Microvascular Angina
- Blood tests including genotyping
- Exercise Tolerance Test
-
Cambridge, United KingdomRoyal Papworth Hospital NHS Foundation Trust
Sep 13, 2021
Metastatic Breast Cancer Trial in Cardiff (Placebo, ZD4054)
Withdrawn
- Metastatic Breast Cancer
- Placebo
- ZD4054
-
Cardiff, United KingdomWales Cancer Trials Unit
May 18, 2018
Scleroderma, Scleroderma Renal Crisis, Chronic Kidney Disease Trial in London (Zibotentan)
Completed
- Scleroderma
- +2 more
- Zibotentan
-
London, United KingdomRoyal Free London NHS Foundation Trust
Oct 30, 2017
Peripheral Arterial Disease, Intermittent Claudication Trial in Charlottesville (Zibotentan (ZD4054), )
Completed
- Peripheral Arterial Disease
- Intermittent Claudication
- Zibotentan (ZD4054)
- placebo
-
Charlottesville, VirginiaUniversity Of Virginia Health System
Aug 1, 2016
Colorectal Cancer Trial in Leicester, Belfast, Cardiff (FOLFIRI regimen, fluorouracil, irinotecan HCl)
Completed
- Colorectal Cancer
- FOLFIRI regimen
- +6 more
-
Leicester, England, United Kingdom
- +3 more
Jul 7, 2014
Prostate Cancer Trial in Germany, United Kingdom, United States (ZD4054 (Zibotentan), Docetaxel, Placebo)
Completed
- Prostate Cancer
- ZD4054 (Zibotentan)
- +2 more
-
Buffalo, New York
- +8 more
Mar 11, 2013
Prostatic Tumors, Metastases, Tumor Trial in Cleveland, Madison (ZD4054 10 mg, ZD4054 15 mg, ZD4054 22.5 mg)
Completed
- Prostatic Neoplasms
- Metastases, Neoplasm
- ZD4054 10 mg
- +2 more
-
Cleveland, Ohio
- +1 more
Oct 23, 2012
Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemo Trial in Germany, Italy (ZD4054 Zibotentan, Paclitaxel,
Terminated
- Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
- ZD4054 Zibotentan
- +3 more
-
Berlin, Germany
- +19 more
Aug 3, 2012
Non Small Cell Lung Cancer, Lung Cancer Trial in Worldwide (ZD4054, Pemetrexed, Placebo)
Completed
- Non Small Cell Lung Cancer
- Lung Cancer
- ZD4054
- +2 more
-
Pleven, Bulgaria
- +12 more
Apr 26, 2012
Advanced Solid Malignancies Trial in Shanghai (ZD4054 (Zibotentan))
Completed
- Advanced Solid Malignancies
- ZD4054 (Zibotentan)
-
Shanghai, Shanghai, ChinaResearch Site
May 18, 2011